Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Kintscher

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Current Cardiology Reports|November 22, 2023
Cardiovascular and Renal Benefit of Novel Non-steroidal Mineralocorticoid Antagonists in Patients with DiabetesUlrich Kintscher
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 4, 2009
ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular hypertrophyUlrich Kintscher
Current Hypertension Reports|June 13, 2015
Benefit of Blood Pressure Control in Diabetic PatientsUlrich Kintscher
Handbook of Experimental Pharmacology|January 18, 2012
Reuptake inhibitors of dopamine, noradrenaline, and serotoninUlrich Kintscher
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
The burden of hypertensionUlrich Kintscher
Deutsche Medizinische Wochenschrift (1946)|June 18, 2015
[Therapy of hypertension--2015]Ulrich Kintscher, Felix Mahfoud
Current Opinion in Investigational Drugs (London, England : 2000)|April 2, 2009
INT-131, a PPARgamma agonist for the treatment of type 2 diabetesUlrich Kintscher, Matthias Goebel
Cardiovascular Diabetology|June 29, 2023
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fractionUlrich Kintscher, Frank Edelmann
American Journal of Physiology. Endocrinology and Metabolism|January 8, 2005
PPARgamma-mediated insulin sensitization: the importance of fat versus muscleUlrich Kintscher, Ronald E Law
Pflugers Archiv : European Journal of Physiology|February 19, 2013
Sex differences in exercise-induced cardiac hypertrophyAnna Foryst-Ludwig, Ulrich Kintscher
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Current Cardiology Reports|November 22, 2023
Cardiovascular and Renal Benefit of Novel Non-steroidal Mineralocorticoid Antagonists in Patients with DiabetesUlrich Kintscher
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 4, 2009
ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular hypertrophyUlrich Kintscher
Current Hypertension Reports|June 13, 2015
Benefit of Blood Pressure Control in Diabetic PatientsUlrich Kintscher
Handbook of Experimental Pharmacology|January 18, 2012
Reuptake inhibitors of dopamine, noradrenaline, and serotoninUlrich Kintscher
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
The burden of hypertensionUlrich Kintscher
Deutsche Medizinische Wochenschrift (1946)|June 18, 2015
[Therapy of hypertension--2015]Ulrich Kintscher, Felix Mahfoud
Current Opinion in Investigational Drugs (London, England : 2000)|April 2, 2009
INT-131, a PPARgamma agonist for the treatment of type 2 diabetesUlrich Kintscher, Matthias Goebel
Cardiovascular Diabetology|June 29, 2023
The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fractionUlrich Kintscher, Frank Edelmann
American Journal of Physiology. Endocrinology and Metabolism|January 8, 2005
PPARgamma-mediated insulin sensitization: the importance of fat versus muscleUlrich Kintscher, Ronald E Law
Pflugers Archiv : European Journal of Physiology|February 19, 2013
Sex differences in exercise-induced cardiac hypertrophyAnna Foryst-Ludwig, Ulrich Kintscher
Pageof 14